Hi Matt, Now that TGTX has a FDA approval for Briumvi , are you back in the company. if yes what is your prediction of the share price- Thanks in advance
I dig your shows, Matt. Cheers. Intriguing dvlptmt, rather devolution in KPTI. I remember missing out on the FDA approval rally way back in 2019, watching it take off to 25$/sh stratosphere, only to come down like Ikarus to 4's. Can U explain WHY the falling from grace, please ? PS check out BLUE.
Bad commercial execution. Bad clinical development decisions (liposarcoma / endometrial cancer). New leadership is trying to turn it around but it takes time. Edit: I noticed blue has some PDUFAs that should go well. r/r probably favors a long
excellent updates in the biopharma area Matt! really appriciate
Hi Matt, Now that TGTX has a FDA approval for Briumvi , are you back in the company. if yes what is your prediction of the share price- Thanks in advance
thank Matt. good stuff. you almost make me feel better about the curis bag I'm holding
Appreciate the analysis. I’m planning to increase my CRIS position too. Current price level is crazy.
I dig your shows, Matt. Cheers.
Intriguing dvlptmt, rather devolution in KPTI.
I remember missing out on the FDA approval rally way back in 2019, watching it take off to 25$/sh stratosphere, only to come down like Ikarus to 4's.
Can U explain WHY the falling from grace, please ?
PS check out BLUE.
Bad commercial execution. Bad clinical development decisions (liposarcoma / endometrial cancer).
New leadership is trying to turn it around but it takes time.
Edit: I noticed blue has some PDUFAs that should go well. r/r probably favors a long